Table 1 Descriptive characteristics of patients with ulnar nerve entrapment (UNE) at any level and registered in Skåne Health Care Register (SHR), combined with data on diabetes from the Swedish National Diabetes Register (NDR) during 2004–2019.
From: Presurgical management of ulnar nerve entrapment in patients with and without diabetes mellitus
No diabetes | Diabetes | |||
|---|---|---|---|---|
Type I | Type II | Total | ||
5786 (89.66) | 123 (1.91) | 544 (8.43) | 667 (10.34) | |
Age (years) | ||||
18–44 | 2216 (38.3) | 43 (35.0) | 42 (7.7) | 85 (12.7) |
45–64 | 2583 (44.6) | 63 (51.2) | 269 (49.5) | 332 (49.8) |
> = 65 | 987 (17.1) | 17 (17.1) | 233 (42.8) | 250 (37.5) |
Sex | ||||
Men | 2797 (48.3) | 73 (55.73) | 497 (60.61) | 394 (59.1) |
Women | 2989 (51.7) | 58 (44.27) | 323 (39.39) | 273 (40.9) |
Surgically treated | ||||
No | 3655 (63.2) | 80 (65.0) | 329 (60.5) | 409 (61.3) |
Yes | 2131 (36.8) | 43 (35.0) | 215 (39.2) | 258 (38.7) |
Level of care | ||||
Primary care | 425 (7.4) | 2 (1.6) | 22 (4.0) | 24 (3.6) |
Specialist care | 5361 (92.7) | 121 (98.4) | 522 (96.0) | 643 (96.4) |
Diabetic retinopathy | ||||
No | 27 (22.1) | 309 (60.5) | 336 (53.1) | |
Yes | 95 (77.9) | 202 (39.5) | 297 (46.9) | |
BMI (kg/m2) | 26.8 ± 4.3 | 31.5 ± 5.2 | 30.6 ± 5.4 | |
Glycemic control | ||||
Optimal | 12 (9.8) | 217 (38.9) | 229 (34.3) | |
Acceptable | 46 (37.4) | 178 (32.7) | 224 (33.6) | |
Poor | 65 (52.9) | 149 (27.4) | 214 (32.1) | |
Creatinine (µmol/l) | 88.7 ± 64.0 | 85.0 ± 35.6 | 85.7 ± 42.3 | |
Diabetes duration (years) | 35.0 ± 14.3 | 14.7 ± 8.7 | 18.5 ± 12.7 | |
GFR | 86.8 ± 25.1 | 80.3 ± 23.3 | 81.5 ± 23.8 | |
